GRHL2 Acts as an Anti-Oncogene in Bladder Cancer by Regulating ZEB1 in Epithelial-Mesenchymal Transition (EMT) Process [Erratum]
Shen J, Lv X, Zhang L. Onco Targets Ther. 2020;13:2511–2522.
The authors have advised the cities are missing from the affiliation list on page 2511. This error was introduced by the Editorial staff during the publication process.
The correct author list and affiliations are as follows.
1Department of Urology, Chengwu County People’s Hospital, Heze City, Shandong 274200, People’s Republic of China; 2Department of Urology, Zoucheng People’s Hospital, Jining City, Shandong 273500, People’s Republic of China
*These authors contributed equally to this work
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF]